To overcome diuretic resistance in congestive heart failure, which approach is commonly recommended?

• A. Increase loop diuretic dose
• B. Add a thiazide-type diuretic such as metolazone
• C. Switch to ACE inhibitors
• D. Start a calcium channel blocker

Answer: (B)

When diuretic resistance occurs in congestive heart failure, the body compensates by increasing sodium reabsorption in parts of the nephron that the loop diuretic doesn’t block. The loop targets the thick ascending limb, but more sodium is reabsorbed downstream in the distal tubule. Introducing a thiazide-type diuretic, such as metolazone, inhibits the Na-Cl cotransporter in the distal tubule, creating sequential nephron blockade. This combination produces a much stronger overall natriuretic effect than the loop alone, and it can be effective even when kidney function is reduced. That’s why adding metolazone is the commonly recommended approach to overcome diuretic resistance.

Be mindful of electrolyte balance and volume status with this strategy. The combination raises the risk of hyponatremia, hypokalemia, and dehydration, so monitor sodium, potassium, magnesium, and kidney function closely and adjust dosing as needed. While increasing the loop diuretic dose might offer a quick bump in diuresis, it often yields diminishing returns and can worsen kidney function or cause volume depletion. ACE inhibitors or calcium channel blockers don’t specifically address the resistance mechanism and are not used to overcome diuretic resistance.